Wave Life Sciences Ltd. ($WVE)
Filing Information
| Accession Number | 0001193125-26-005195 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
28,125
Total Value
$179,697.60
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Jan 2, 2026 | Exercise/Conversion | 9,375 | $3.14 | $29,437.50 | 34,375 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Jan 2, 2026 | Sale | 8,080 | $15.92 | $128,633.60 | 26,295 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Jan 2, 2026 | Sale | 1,295 | $16.70 | $21,626.50 | 25,000 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Share Option (right to buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 9,375 | $0.00 | $0.00 | 0 | Direct | โ | View Details |